Q4 2019 13F Holders as of 31 Dec 2019
-
Type / Class
-
Equity / Common Stock, $0.001 par value per share
-
Shares outstanding
-
384,731,503
-
Total 13F shares
-
63,091,597
-
Share change
-
-283,212
-
Total reported value
-
$219,541,158
-
Price per share
-
$3.48
-
Number of holders
-
96
-
Value change
-
-$9,645,262
-
Number of buys
-
45
-
Number of sells
-
70
Institutional Holders of STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) as of Q4 2019
As of 31 Dec 2019,
STANDARD BIOTOOLS INC. - Common Stock, $0.001 par value per share (LAB) was held by
96 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
63,091,597 shares.
The largest 10 holders included
PRIMECAP MANAGEMENT CO/CA/, Russell Investments Group, Ltd., Neuberger Berman Group LLC, BlackRock Inc., VANGUARD GROUP INC, Levin Easterly Partners LLC, Indaba Capital Management, L.P., Partner Fund Management, L.P., RENAISSANCE TECHNOLOGIES LLC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
96
institutional shareholders reporting positions in this security
for the Q4 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.